SUPRAMOLECULAR CHEMISTRY
3
3.52 (br. s., 4H). 13C (125 MHz, CDCl3): δ 148.8, 147.9,
Calculated
423.12712.
for
C48H46O10S22−423.12717,
Found
131.6, 130.2, 129.3, 127.5, 122.52, 114.0, 31.5. HR-ESI-MS
([M−H]−, m/z): Calculated for C28H21Br2O4 578.98121,
−
Found 578.98106.
Results and discussion
5,17-dibromo-25,26,27,28-tetrahydroxy-11,23-
disulfonatocalix[4]arene (6).
The synthesis of 2 is achieved through selective upper-
rim functionalization reactions. It starts with the selec-
tive dibromination of 1,3-dibenzoyl calix[4]arene (3)
(19) which occurs selectively at the two positions para
to unprotected phenols to give 4. The benzoyl groups
are removed (5) and the newly exposed phenols are
para sulfonated along the upper rim upon treatment
with H2SO4 to yield the key precursor 6. The final
compound, 2, is obtained by a double Suzuki coupling
with t-butylphenyl boronic acid and obtained in 40%
yield after HPLC purification. Compound 2 is most solu-
ble in slightly basic water, at which it is expected to
have a net charge of – 3 due to the low pKa for the first
phenol deprotonation in calix[4]arenes (20).
Dimerization of 2 was apparent when comparing the
1H NMR spectra in CD3OD and D2O. In CD3OD, the
pendant phenyl and t-butyl resonances were found as
sharp peaks at 7.45 ppm, 7.40 ppm and 1.32 ppm, as
expected for an unaggregated monomeric state. In
D2O both the phenyl and t-butyl resonances broadened
and shifted upfield to 7.25 ppm, 7.0 ppm and 0.33 ppm,
respectively (Figure S2). This pattern of upfield shifts is
diagnostic for encapsulation of a t-butylphenyl substi-
tuent within a calix[4]arene’s electron-rich pocket (13).
The fact that this is not observed in pure CD3OD (or
even upon addition of small amounts of
CD3OD) indicates that the dimerization is primarily dri-
ven by the hydrophobic effect.
Compound 5 (50 mg, 86 μmol) was dissolved in
CH2Cl2 (2 mL) followed with conc. H2SO4 (100 μL). The
reaction was heated to reflux for 24 h to afford a
residue. The CH2Cl2 was decanted, and the residue
was rinsed with fresh CH2Cl2. The solid was suspended
in EtOAc, transferred into a conical tube and diluted
with cold Et2O. The suspension was centrifuged to a
pellet, the supernatant was decanted and the resuspen-
sion/centrifugation/decanting process was repeated
three times. The pellet was left to air dry overnight to
afford a gray solid (51 mg, 81%). Mp: decomposed
> 178 °C. IR (KBr disc) (cm−1): 2408 (br), 3221 (br),
2961 (w), 1651 (m), 1204 (m), 1163 (m), 1036 (m), 625
(m). 1H NMR (500 MHz, d6-DMSO): δ 9.62 (br. s, 7H), 7.43
(s, 4H), 7.28 (s, 4H), 3.89 (br. s, 8H). 13C NMR (125 MHz,
d6-DMSO): δ 151.6, 149.8, 140.0, 131.5, 131.3, 127.6,
127.0, 112.3, 41.0, 30.6. HR-ESI-MS ([M−2H]2−, m/z):
2−
Calculated for C28H20Br2O10S2
368.94376.
368.94378, Found
5,17-di(4-t-butylphenyl)-25,26,27,28-tetrahydroxy-
11,23-disulfonatocalix[4]arene (2).
Compound 6 (50 mg, 67 μmol), t-butyl-phenylboronic
acid (26 mg, 148 μmol), K2CO3 (74 mg, 0.51 mmol) and
Pd(OAc)2 (5 mg, 22 μmol) were dissolved in a micro-
wave vial with 3 mL of 1:1 EtOH:deionized water. The
reaction was irradiated to a temperature of 150 °C for
5 minutes with cooling air and stirring on (Biotage
Initiator Microwave Reactor). After, thiourea (1 M,
0.5 mL) was added and the reaction stirred at 90°C for
1 h. The solution was filtered through a PDVF syringe
filer (0.45 μm), and concentrated until solution became
cloudy. The slurry was re-dissolved with small amounts
of CH3CN and purified by HPLC purification with a
gradient running from 90% H2O (+ 0.1% TFA)/10%
CH3CN (+ 0.1% TFA) to 40% H2O (+ 0.1% TFA)/60%
CH3CN (+ 0.1% TFA) over 18 minutes. Lyophilization of
collected fractions afforded a white powder in 40%
yield (22 mg). Mp: decomposed > 190 °C. FT-IR (cm−1):
3398 (br), 2962 (m), 2874 (w), 1456 (m), 1268 (m), 1153
(m), 1038 (s), 822/32 (m), 750 (s), 629 (s), 542 (s). 1H NMR
(500 MHz, CD3OD): δ 7.69 (s, 4H), 7.44 (s, J = 7.4 Hz, 4H),
7.41 (s, 4H), 7.39 (d, J = 7.4 Hz, 4H), 4.07 (br. s, 8H), 1.31
(s, 18H). 13C NMR (125 MHz, d6-DMSO): δ 151.0, 149.52,
149.50, 140.2, 137.5, 133.7, 129.2, 128.3, 127.5, 126.9,
126.4, 125.9, 34.6, 31.6, 31.1. HR-MS ([M−2H]2−, m/z):
The existence of dimer in solution was confirmed by
DOSY. The diffusion coefficient of monomeric 2 was
obtained by 1-D DOSY in 20% CD3OD in Na2HPO4/
NaH2PO4 (50 mM, pD 8.5) buffer – conditions under
which 1D chemical shifts show that pure monomer is
present. The Stokes-Einstein equation was used to
determine the monomer’s hydrodynamic radius as
8.51 Å (Table 1). This value is similar to the value
determined in the same CD3OD/buffer conditions for
Table 1. Diffusion coefficients obtained by 1-D DOSY and
corresponding hydrodynamic radii.
D (m2/s)
rH (Å)
7.3
8.51 0.03
11.31 0.04
11.3
PSC(a) (monomer control)
2(a) (monomer)
2(b) (dimer)
2.2 × 10−10
1.9 × 10−10
2.2 × 10−10
1.5 × 10−10
1(c) (dimer)
(a) 20% CD3OD in Na2HPO4/NaH2PO4 (50 mM, pD 8.5) buffer, [PSC] or
[2] = 1 mM.
(b) Na2HPO4/NaH2PO4 (50 mM, pD 8.5) buffer
(c)previously reported data (13), in D2O.